These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 37240042)
1. The Role of Dopamine D3 Receptors, Dysbindin, and Their Functional Interaction in the Expression of Key Genes for Neuroplasticity and Neuroinflammation in the Mouse Brain. Rivi V; Benatti C; Blom JMC; Pani L; Brunello N; Drago F; Papaleo F; Caraci F; Geraci F; Torrisi SA; Leggio GM; Tascedda F Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240042 [TBL] [Abstract][Full Text] [Related]
2. The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans. Leggio GM; Torrisi SA; Mastrogiacomo R; Mauro D; Chisari M; Devroye C; Scheggia D; Nigro M; Geraci F; Pintori N; Giurdanella G; Costa L; Bucolo C; Ferretti V; Sortino MA; Ciranna L; De Luca MA; Mereu M; Managò F; Salomone S; Drago F; Papaleo F Mol Psychiatry; 2021 Apr; 26(4):1272-1285. PubMed ID: 31492942 [TBL] [Abstract][Full Text] [Related]
4. Dysbindin-1 modifies signaling and cellular localization of recombinant, human D₃ and D₂ receptors. Schmieg N; Rocchi C; Romeo S; Maggio R; Millan MJ; Mannoury la Cour C J Neurochem; 2016 Mar; 136(5):1037-51. PubMed ID: 26685100 [TBL] [Abstract][Full Text] [Related]
5. Dopamine receptor D1 but not D3 essential for morphine-induced conditioned responses. Wang YP; Wei SG; Zhu YS; Zhao B; Xun X; Lai JH Genet Mol Res; 2015 Jan; 14(1):180-9. PubMed ID: 25729949 [TBL] [Abstract][Full Text] [Related]
6. Involvement of DA D3 Receptors in Structural Neuroplasticity of Selected Limbic Brain Circuits: Possible Role in Treatment-Resistant Depression. Merlo Pich E; Cavalleri L; Toma C; Collo G Curr Top Behav Neurosci; 2023; 60():73-87. PubMed ID: 35538302 [TBL] [Abstract][Full Text] [Related]
7. The dopamine D1 but not D3 receptor plays a fundamental role in spatial working memory and BDNF expression in prefrontal cortex of mice. Xing B; Guo J; Meng X; Wei SG; Li SB Behav Brain Res; 2012 Nov; 235(1):36-41. PubMed ID: 22776159 [TBL] [Abstract][Full Text] [Related]
8. Ethologically based behavioural and neurochemical characterisation of mice with isoform-specific loss of dysbindin-1A in the context of schizophrenia. O'Tuathaigh CMP; Desbonnet L; Payne C; Petit E; Cox R; Loftus S; Clarke G; Cryan JF; Tighe O; Wilson S; Kirby BP; Dinan TG; Waddington JL Neurosci Lett; 2020 Sep; 736():135218. PubMed ID: 32615248 [TBL] [Abstract][Full Text] [Related]
9. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine. Guillin O; Demily C; Thibaut F Int Rev Neurobiol; 2007; 78():377-95. PubMed ID: 17349867 [TBL] [Abstract][Full Text] [Related]
10. Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways. Papaleo F; Yang F; Garcia S; Chen J; Lu B; Crawley JN; Weinberger DR Mol Psychiatry; 2012 Jan; 17(1):85-98. PubMed ID: 20956979 [TBL] [Abstract][Full Text] [Related]
11. Regulation of Brain-Derived Neurotrophic Factor Exocytosis and Gamma-Aminobutyric Acidergic Interneuron Synapse by the Schizophrenia Susceptibility Gene Dysbindin-1. Yuan Q; Yang F; Xiao Y; Tan S; Husain N; Ren M; Hu Z; Martinowich K; Ng JS; Kim PJ; Han W; Nagata KI; Weinberger DR; Je HS Biol Psychiatry; 2016 Aug; 80(4):312-322. PubMed ID: 26386481 [TBL] [Abstract][Full Text] [Related]
13. [Risk genes for schizophrenia and neuronal plasticity: molecular target for antipsychotic discovery]. Hashimoto R; Yasuda Y; Ohi K; Fukumoto M; Yamamori H; Takeda M Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Jun; 30(3):103-7. PubMed ID: 20666140 [TBL] [Abstract][Full Text] [Related]
14. Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment. Stark T; Di Bartolomeo M; Di Marco R; Drazanova E; Platania CBM; Iannotti FA; Ruda-Kucerova J; D'Addario C; Kratka L; Pekarik V; Piscitelli F; Babinska Z; Fedotova J; Giurdanella G; Salomone S; Sulcova A; Bucolo C; Wotjak CT; Starcuk Z; Drago F; Mechoulam R; Di Marzo V; Micale V Biochem Pharmacol; 2020 Jul; 177():114004. PubMed ID: 32360362 [TBL] [Abstract][Full Text] [Related]
15. Role of dysbindin in dopamine receptor trafficking and cortical GABA function. Ji Y; Yang F; Papaleo F; Wang HX; Gao WJ; Weinberger DR; Lu B Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19593-8. PubMed ID: 19887632 [TBL] [Abstract][Full Text] [Related]
16. Lack of BDNF expression through promoter IV disturbs expression of monoamine genes in the frontal cortex and hippocampus. Sakata K; Duke SM Neuroscience; 2014 Feb; 260():265-75. PubMed ID: 24345476 [TBL] [Abstract][Full Text] [Related]
17. Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients. Liou YJ; Liao DL; Chen JY; Wang YC; Lin CC; Bai YM; Yu SC; Lin MW; Lai IC Neuromolecular Med; 2004; 5(3):243-51. PubMed ID: 15626824 [TBL] [Abstract][Full Text] [Related]
18. Dysbindin-1 Involvement in the Etiology of Schizophrenia. Wang H; Xu J; Lazarovici P; Zheng W Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937620 [TBL] [Abstract][Full Text] [Related]
19. Dysbindin regulates hippocampal LTP by controlling NMDA receptor surface expression. Tang TT; Yang F; Chen BS; Lu Y; Ji Y; Roche KW; Lu B Proc Natl Acad Sci U S A; 2009 Dec; 106(50):21395-400. PubMed ID: 19955431 [TBL] [Abstract][Full Text] [Related]